Credage Mv 1/500/0.2 MG Tablet 10

Credage Mv 1/500/0.2 MG Tablet 10 is used for managing type 2 diabetes when single medicines are not sufficient. It helps lower blood sugar by improving insulin sensitivity and reducing glucose production in the body. The tablet supports better glycaemic control and helps prevent diabetes-related complications.

• Swallow the tablet whole with a glass of water.
• Do not crush, chew, or cut the tablet.
• Do not take more than the dose recommended by your doctor.
• Always consult your doctor before stopping this medicine.

Credage Mv 1/500/0.2 MG Tablet 10 is taken orally.

Credage Mv 1/500/0.2 MG Tablet 10 consists of three active ingredients:

• Glimepiride (1 mg): As a sulfonylurea, it stimulates insulin secretion from functioning pancreatic beta cells by binding to their surface receptors. This activity promotes an increase in intracellular calcium that triggers insulin secretion.
• Metformin (500 mg): This biguanide reduces glucose production by the liver, decreases intestinal absorption of glucose, and improves insulin sensitivity by enhancing peripheral glucose absorption and utilisation. It activates a liver enzyme known as AMPK to regulate these processes.
• Voglibose (0.2 mg): It is an alpha-glucosidase inhibitor that slows down carbohydrate digestion and absorption within the intestines. This action helps reduce post-meal glucose and insulin levels.

• Maintain an ideal storage environment for Credage Mv 1/500/0.2 MG Tablet 10 at room temperature.
• Protect the medicine from excessive heat, moisture, and direct sunlight.
• Ensure the medicine is securely stored out of reach of children.
• Be mindful of the expiration date on the packaging and use the medicine before this date.

• Incorporate a balanced diet rich in fibre and low in sugar to manage your blood glucose levels.
• Regular physical activity, such as walking or yoga, can help improve insulin sensitivity and support the effectiveness of this medication.